BioSig Technologies entered a securities purchase agreement, selling 1.8 million shares at $1.3905 per share. This news directly impacts BSGM as it raises capital for the company. However, the short-term price impact is uncertain as the market may react positively to the capital raise or negatively to the dilution of shares.